Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.
<h4>Background</h4>Lisinopril and losartan manufacturer labels recommend twice-daily dosing (BID) if once-daily (QDay) is insufficient to lower blood pressure (BP).<h4>Methods and results</h4>Retrospective cohort study of patients taking QDay lisinopril and losartan who exper...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2020-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0243371&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|